Trial Profile
Absorption, distribution, metabolism, and excretion (ADME) of 14C-sonidegib (LDE225) in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Sonidegib (Primary)
- Indications Basal cell cancer; Medulloblastoma
- Focus Pharmacokinetics
- 11 Dec 2015 New trial record